Anomalies pariétales et de la flore au cours du syndrome de l’intestin irritable

Piche, 2002, Role of enteric infections and inflammation in functional bowel disorders, Gastroenterol Clin Biol, 26, 624

Dainese, 1999, Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients, Am J Gastroenterol, 94, 1892, 10.1111/j.1572-0241.1999.01226.x

Tibble, 2002, Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease, Gastroenterology, 123, 450, 10.1053/gast.2002.34755

Lobley, 1990, Simultaneous assessment of intestinal permeability and lactose tolerance with orally administered raffinose, lactose and L-arabinose, Clin Sci (Lond), 79, 175, 10.1042/cs0790175

Marshall, 2004, Intestinal permeability in patients with irritable bowel syndrome after a waterbone outbreak of acute gastroenteritis in Walkerton, Ontario, Aliment Pharmacol Therap, 20, 1317, 10.1111/j.1365-2036.2004.02284.x

Spiller, 2000, Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome, Gut, 47, 804, 10.1136/gut.47.6.804

Dunlop, 2006, Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes, Am J Gastroenterol, 101, 1288, 10.1111/j.1572-0241.2006.00672.x

Gecse, 2008, Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity, Gut, 57, 591, 10.1136/gut.2007.140210

Piche, 2009, Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome patients: involvement of soluble mediators, Gut, 58, 196, 10.1136/gut.2007.140806

Hiatt, 1962, Mast cells in inflammatory conditions of the gastrointestinal tract, Am J Gastroenterol, 37, 541

Salzmann, 1989, Morphometric study of colonic biopsies: a new method of estimating inflammatory diseases, Lab Invest, 60, 847

Chadwick, 2002, Activation of the mucosal immune system in irritable bowel syndrome, Gastroenterology, 122, 1778, 10.1053/gast.2002.33579

Talley, 2003, Pharmacologic therapy for the irritable bowel syndrome, Am J Gastroenterol, 98, 750, 10.1111/j.1572-0241.2003.07306.x

Dunlop, 2003, Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome, Am J Gastroenterol, 98, 1578, 10.1111/j.1572-0241.2003.07542.x

Gwee, 1996, Psychometric scores and persistence of irritable bowel after infectious diarrhoea, Lancet, 347, 150, 10.1016/S0140-6736(96)90341-4

Dunlop, 2005, Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome, Clin Gastroenterol Hepatol, 3, 349, 10.1016/S1542-3565(04)00726-8

El-Salhy, 1997, Colonic endocrine cells in inflammatory bowel disease, J Intern Med, 242, 413, 10.1046/j.1365-2796.1997.00237.x

Wheatcroft, 2005, Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction, Neurogastroenterol Motil, 17, 863, 10.1111/j.1365-2982.2005.00719.x

Coates, 2004, Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome, Gastroenterology, 126, 1657, 10.1053/j.gastro.2004.03.013

Camilleri, 2007, Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome, Gastroenterology, 132, 17, 10.1053/j.gastro.2006.11.020

Tornblom, 2002, Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome, Gastroenterology, 123, 1972, 10.1053/gast.2002.37059

O'Sullivan, 2000, Increased mast cells in the irritable bowel syndrome, Neurogastroenterol Motil, 12, 449, 10.1046/j.1365-2982.2000.00221.x

Piche, 2008, Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome, Gut, 57, 468, 10.1136/gut.2007.127068

Guilarte, 2007, Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum, Gut, 56, 203, 10.1136/gut.2006.100594

Barbara, 2004, Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome, Gastroenterology, 126, 693, 10.1053/j.gastro.2003.11.055

Barbara, 2007, Mast cell-dependent excitation of visceralnociceptive sensory neurons in irritable bowel syndrome, Gastroenterology, 132, 26, 10.1053/j.gastro.2006.11.039

Roka, 2007, A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome, Clin Gastroenterol Hepatol, 5, 550, 10.1016/j.cgh.2006.12.004

Cenac, 2007, Role for protease activity in visceral pain in irritable bowel syndrome, J Clin Invest, 117, 636, 10.1172/JCI29255

Akiho, 2005, Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction, Gastroenterology, 129, 131, 10.1053/j.gastro.2005.03.049

McFarland, 2008, Meta-analysis of probiotics for the treatment of irritable bowel syndrome, World J Gastroenterol, 14, 2650, 10.3748/wjg.14.2650

Frissora, 2007, Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome, Aliment Pharmacol Ther, 25, 1271, 10.1111/j.1365-2036.2007.03313.x

Chaudhary, 1962, The irritable bowel syndrome, Quart J Med, 31, 307

McKendrick, 1994, Irritable bowel syndrome-post salmonella infection, J Infect, 39, 1, 10.1016/S0163-4453(94)94871-2

Gwee, 2003, Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome, Gut, 52, 523, 10.1136/gut.52.4.523

Neal, 1997, Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients, BMJ, 314, 779, 10.1136/bmj.314.7083.779

Marshall, 2006, Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery, Gastroenterology, 131, 445, 10.1053/j.gastro.2006.05.053

Piche, 2007, Low risk of irritable bowel syndrome after Clostridium difficile infection, Can J Gastroenterol, 21, 727, 10.1155/2007/262478

Si, 2004, Intestinal microecology and quality of life in irritable bowel syndrome patients, World J Gastroenterol, 10, 1802, 10.3748/wjg.v10.i12.1802

Mättö, 2005, Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-a longitudinal study in IBS and control subjects, FEMS Immunol Med Microbiol, 43, 213, 10.1016/j.femsim.2004.08.009

Kassinen, 2007, The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects, Gastroenterology, 133, 24, 10.1053/j.gastro.2007.04.005

Furrie, 2005, Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria, Immunology, 115, 565, 10.1111/j.1365-2567.2005.02200.x

Hart, 2004, Modulation of human dendritic cell phenotype and function by probiotic bacteria, Gut, 53, 1602, 10.1136/gut.2003.037325

King, 1998, Abnormal colonic fermentation in irritable bowel syndrome, Lancet, 352, 1187, 10.1016/S0140-6736(98)02146-1

Salvioli, 2005, Origin of gas retention and symptoms in patients with bloating, Gastroenterology, 128, 574, 10.1053/j.gastro.2004.12.047

Pimentel, 2000, Eradication of small intestinal bacterial overgrowth reduces symptoms in irritable bowel syndrome, Am J Gastroenterol, 95, 3503, 10.1111/j.1572-0241.2000.03368.x

Pimentel, 2003, Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double blind, randomized controlled study, Am J Gastroenterol, 98, 412

Walters, 2005, Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls, Am J Gastroenterol, 100, 1566, 10.1111/j.1572-0241.2005.40795.x

Esposito, 2007, Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics, World J Gastroenterol, 13, 6016, 10.3748/wjg.13.6016

Grover, 2008, Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress, Neurogastroenterol Motil, 20, 998, 10.1111/j.1365-2982.2008.01142.x

Majewski, 2007, Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial, Adv Med Sci, 52, 139

Sharara, 2006, A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence, Am J Gastroenterol, 101, 326, 10.1111/j.1572-0241.2006.00458.x

Posserud, 2006, Functional findings in irritable bowel syndrome, World J Gastroenterol, 12, 2830, 10.3748/wjg.v12.i18.2830